Strategic Acquisition Aluna recently became the target of a strategic acquisition by Huma Therapeutics, expanding US presence and potentially opening up cross-selling opportunities for respiratory management solutions and indirect channel partnerships.

Financial Upside With a Series B funding of 15.3 million and annual revenue in the low-to-mid single digits, there is a clear investment trajectory and upsell potential for expanded healthcare IT, EHR integrations, and advanced spirometry analytics.

Healthcare Partnerships Existing collaboration with ModuleMD LLC to integrate EHR and practice management capabilities signals appetite for deeper health-system integrations and enterprise contracts with pulmonology and allergy clinics.

Technology Stack Utilizes a modern frontend stack and cloud security measures, suggesting potential for scalable SaaS add-ons, data analytics modules, and compliance-ready integrations with medical device data to attract larger practice networks.

Market Position Focused on at‑home lung health management with machine learning and mobile app, presenting a recurring revenue opportunity through subscription models, premium features, and expanded remote patient monitoring offerings for chronic respiratory care.